Antithyroid drugs and birth defects

Research output: Contribution to journalReview articlepeer-review

18 Citations (Scopus)
67 Downloads (Pure)

Abstract

Antithyroid drugs (ATDs) are preferred for the treatment of hyperthyroidism caused by Graves' disease in pregnant women. The drugs have been a recognized treatment for decades, and a general risk of side effects is known. For the use of ATDs in pregnancy, a concern about teratogenic side effects has been brought forward since the 1970s. In more recent years, a number of large observational studies have added new evidence and quantified the risk of birth defects associated with different types of ATDs. The findings that both Methimazole (MMI) and Propylthiouracil (PTU) are associated with birth defects have challenged the clinical recommendations on the treatment of hyperthyroidism in pregnancy, and certain aspects remain unclarified. In this review, the current evidence on the risk of birth defects associated with the use of ATDs in early pregnancy is described, and determinants of causality are discussed. This includes the current evidence of a biological gradient and the role of maternal thyroid function per se. Finally, clinical aspects of the timing and type of treatment is discussed, and future perspectives are addressed. Current evidence corroborates a risk of birth defects associated with MMI while more evidence is needed to determine the teratogenic potential of PTU. Detailed assessment of type and timing of exposure in large cohorts are needed. Moreover, studies investigating alternative or new treatments are warranted.

Original languageEnglish
Article number11
JournalThyroid research
Volume13
Issue number1
ISSN1756-6614
DOIs
Publication statusPublished - 2020

Keywords

  • Antithyroid drugs
  • Birth defects
  • Carbimazole
  • Congenital malformations
  • Graves' disease
  • Hyperthyroidism
  • Methimazole
  • Pregnancy
  • Propylthiouracil

Fingerprint

Dive into the research topics of 'Antithyroid drugs and birth defects'. Together they form a unique fingerprint.

Cite this